This provider's $26.6M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
Medicare payments to this provider grew 36150% from 2015 to 2023.
AI-generated analysis based on Medicare payment data.
Notable: Payments increased 1531% in 2016
Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2015 | $115.89 | $25.31 | 4.58x | $90.58 | $12.5K | 495 | 8 |
| 2016 | $1.6K | $128.98 | 12.36x | $1.5K | $204.3K | 1.6K | 6 |
| 2017 | $1.2K | $117.01 | 10.56x | $1.1K | $304.0K | 2.6K | 18 |
| 2018 | $981.03 | $93.02 | 10.55x | $888.01 | $998.7K | 10.7K | 38 |
| 2019 | $1.0K | $134.63 | 7.48x | $872.46 | $1.8M | 13.4K | 42 |
| 2020 | $737.68 | $249.23 | 2.96x | $488.45 | $6.0M | 24.2K | 42 |
| 2021 | $718.87 | $265.43 | 2.71x | $453.44 | $9.6M | 36.3K | 26 |
| 2022 | $104.21 | $48.51 | 2.15x | $55.70 | $3.0M | 62.7K | 26 |
| 2023 | $80.85 | $42.61 | 1.90x | $38.24 | $4.5M | 106.6K | 36 |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81408 | Molecular pathology procedure level 9 | 2.8K | $5.6M | $2.0K | 1.50x |
| 87798 | Detection test by nucleic acid for organism, amplified probe technique | 92.6K | $3.2M | $34.47 | 1.69x |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 9.9K | $1.9M | $195.91 | 8.14x |
| 81411 | Test for detecting genes associated with heart disease, duplication/deletion analysis panel | 1.3K | $1.8M | $1.3K | 1.50x |
| 81404 | Molecular pathology procedure level 5 | 4.8K | $1.3M | $274.16 | 1.50x |
| 81407 | Molecular pathology procedure level 8 | 1.5K | $1.3M | $845.05 | 1.50x |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 4.7K | $1.1M | $239.47 | 12.53x |
| 80307 | Testing for presence of drug, by chemistry analyzers | 17.1K | $1.1M | $64.41 | 7.84x |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 6.6K | $1.0M | $154.46 | 7.64x |
| 81405 | Molecular pathology procedure level 6 | 3.0K | $901.2K | $300.91 | 1.50x |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 7.5K | $839.2K | $112.64 | 5.27x |
| 81406 | Molecular pathology procedure level 7 | 3.0K | $837.2K | $282.46 | 1.51x |
| 81439 | Test for detecting genes associated with inherited disease of heart muscle | 1.3K | $780.8K | $584.44 | 1.50x |
| 87481 | Detection test for candida species (yeast), amplified probe technique | 20.4K | $705.0K | $34.48 | 1.84x |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 7.2K | $587.3K | $82.06 | 6.42x |
| 81161 | Gene analysis (dystrophin) | 1.3K | $371.3K | $279.00 | 1.50x |
| 81403 | Molecular pathology procedure level 4 | 1.5K | $283.5K | $184.94 | 1.51x |
| 87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 7.0K | $241.0K | $34.52 | 1.95x |
| 87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 6.9K | $238.8K | $34.50 | 1.96x |
| 81401 | Molecular pathology procedure level 2 | 1.6K | $224.1K | $136.65 | 1.53x |
This provider submits charges 3.35 times higher than what Medicare actually pays.
A markup ratio of 3.35x means for every $100 Medicare pays, this provider initially charges $335. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in PA for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Quest Diagnostics Clinical Laboratories Inc | Norristown, PA | $340.6M | ✓ Clear |
| Quest Diagnostics Of Pennsylvania, Inc. | Pittsburgh, PA | $130.4M | ⚠️ Flagged |
| Health Network Laboratories, Llc | Allentown, PA | $125.3M | ⚠️ Flagged |
| Sma Medical, Inc. | Feasterville, PA | $100.9M | ✓ Clear |
| Interpace Diagnostics Corporation | Pittsburgh, PA | $95.6M | ✓ Clear |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data